We found increased levels of clusterin, LSR1, and LRP11 and decreased levels of apoF in the CSF of SMA patients under Nusinersen therapy compared to TN CSF, again indicating changed HDL function. This evidence concerns the gene LRP11 and proximal spinal muscular atrophy.